A deadly and common side-effect of lifesaving bone marrow transplants.

Alpha-1-antitrypsin might reduce ramifications of GVHD A natural enzyme derived from human blood plasma showed potential in significantly reducing the effects of graft-vs.-host disease, a deadly and common side-effect of lifesaving bone marrow transplants. Experts from the University of Michigan Comprehensive Cancer Center looked at the drug alpha-1-antitrypsin, which is definitely authorized by the U over the counter here .S. Food and Drug Administration for use in people who have a genetic mutation that makes them deficient in a certain enzyme.

here

If we can learn more about this process, we may find new methods to keep cancer in check.’ Toward that goal, Wirtz, who is associate director of the Johns Hopkins Institute for NanoBioTechnology, led a multi-institution group that focused on alpha-catenin, a small proteins that floats in the cytoplasm, the gel-like material that surrounds the nucleus in the cell. Alpha-catenin allows cells to identify neighboring cells as ‘friends’ in less than one millisecond, resulting in the creation of several strong bonds that are hard to break.

Other entries from category "venereology":

Random entries